Posted on

Pneumococcal Conjugate Vaccine (PCV) for elderly adults 60 years old and above

General Track – Cycle 1 | Vaccines

HTA Council Preliminary Recommendation (as of 19 September 2025)

As a preliminary recommendation, the HTA Council recommends the government to finance the pneumococcal polysaccharide vaccine (PPSV23) for all adults 60 years old and older.

Relevant Information

  • Status: with Preliminary HTA Council Recommendation
  • Topic Assignment: External Assessment
  • Policy Question: Should PCV-13 or PCV-15 as sequential vaccination with PPSV23 vs. PPSV23 alone for the immunization of all elderly adults 60 years old and above against diseases caused by Streptococcus pneumoniae be recommended for government financing?
  • Secretary of Health Decision: pending

Evidence and Relevant Documents

Back to Assessments Page